Selective dependence of intracerebroventricular neuropeptide Y-elicited effects on central glucocorticoids.
It has been reported that hyperphagia and excessive body weight gain of genetically obese rodents were abolished by adrenalectomy. High hypothalamic levels of neuropeptide Y (NPY) were found in obese rodents. A chronic intracerebroventricular (icv) infusion of NPY in normal rats was shown to produce most hormono-metabolic abnormalities of genetically obese animals, and to be inefficient in doing so in adrenalectomized (ADX) rats. The combined presence of NPY and of glucocorticoids thus appeared to be necessary for inducing obesity. This study, therefore, was aimed at determining the consequences of a chronic i.c.v. NPY infusion in ADX rats receiving or not i.c.v. glucocorticoids. It was found that the combined i.c.v. infusion of NPY and dexamethasone in ADX rats increased food intake, body weight, plasma insulin, leptin, and triglyceride levels relative to vehicle-infused ADX controls. The infusion of NPY alone, or of dexamethasone alone in ADX rats failed to produce these effects. In contrast, the icv infusion of NPY alone greatly decreased the expression of brown adipose tissue uncoupling protein-1 and -3. This was not modified by the superimposed infusion of dexamethasone. It is concluded that, although many of centrally elicited NPY effects require the central presence of glucocorticoids, those bearing on the inhibition of uncoupling proteins expression (energy dissipation) do not require central glucocorticoids.
Zakrzewska
K E
KE
Laboratoires de Recherches Métaboliques, Geneva University, School of Medicine, Switzerland. katerina_z@hotmail.com
Sainsbury
A
A
Cusin
I
I
Rouru
J
J
Jeanrenaud
B
B
Rohner-Jeanrenaud
F
F
D002001:Adipose Tissue, Brown / Q000378:metabolism; D000315:Adrenalectomy; D000818:Animals; D001835:Body Weight / Q000187:drug effects; D001921:Brain / Q000378:metabolism*; D002352:Carrier Proteins / Q000378:metabolism; D003907:Dexamethasone / Q000494:pharmacology; D004338:Drug Combinations; D004435:Eating / Q000187:drug effects; D005260:Female; D005938:Glucocorticoids / Q000378:metabolism* / Q000494:pharmacology; D007276:Injections, Intraventricular; D007328:Insulin / Q000097:blood; D007473:Ion Channels; D020738:Leptin; D008565:Membrane Proteins / Q000378:metabolism; D024101:Mitochondrial Proteins; D009478:Neuropeptide Y / Q000494:pharmacology*; D011506:Proteins / Q000032:analysis; D051381:Rats; D017207:Rats, Sprague-Dawley; D014280:Triglycerides / Q000097:blood; D000071256:Uncoupling Protein 1
D002352:Carrier Proteins; D004338:Drug Combinations; D005938:Glucocorticoids; D007328:Insulin; D007473:Ion Channels; D020738:Leptin; D008565:Membrane Proteins; D024101:Mitochondrial Proteins; D009478:Neuropeptide Y; D011506:Proteins; D014280:Triglycerides; C000604373:Ucp1 protein, rat; D000071256:Uncoupling Protein 1; D003907:Dexamethasone